Published in Klin Padiatr on August 20, 2003
Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit. Intensive Care Med (2014) 0.97
G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer (2006) 0.88
The critically-ill pediatric hemato-oncology patient: epidemiology, management, and strategy of transfer to the pediatric intensive care unit. Ann Intensive Care (2012) 0.82
Assessing the risk of mortality in paediatric cancer patients admitted to the paediatric intensive care unit: a novel risk score? Eur J Pediatr (2005) 0.80
Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest (1997) 1.62
Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nat Med (1996) 1.61
Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol (1998) 1.47
Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Biol Blood Marrow Transplant (2001) 1.25
Childhood asthma in four countries: a comparative survey. Int J Epidemiol (1994) 1.25
The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation. J Exp Med (1996) 1.13
IL-7 deficiency prevents development of a non-T cell non-B cell-mediated colitis. J Immunol (1998) 1.11
Intracranial hemorrhage in immune thrombocytopenia (ITP): fatal course in spite of maximum therapy. Klin Padiatr (2010) 1.06
Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry. Bone Marrow Transplant (1995) 1.04
High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant (1997) 1.04
Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Klin Padiatr (1998) 1.02
A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study. Ann Rheum Dis (2001) 1.01
Malignant peripheral neuroectodermal tumours of childhood and adolescence. Virchows Arch A Pathol Anat Histopathol (1985) 0.98
Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol (1997) 0.96
Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours. Virchows Arch (1994) 0.95
Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant (1997) 0.94
Effects of heat shock on the functional morphology of cell organelles observed by video-enhanced microscopy. Anat Rec (1999) 0.93
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study. Transplantation (1995) 0.92
Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis. Blood (1998) 0.91
Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells. Br J Cancer (2011) 0.91
First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol (2010) 0.90
The insulin-like growth factor system in normal and malignant hematopoietic cells. Blood (1999) 0.90
High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients. Ann Oncol (2012) 0.90
C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol (1997) 0.89
Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol (1998) 0.89
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol (2011) 0.88
Targeted therapeutics in treatment of children and young adults with solid tumors: an expert survey and review of the literature. Klin Padiatr (2012) 0.86
Ovarian sex cord tumor with annular tubules associated with precocious puberty. Med Pediatr Oncol (2000) 0.86
Disposition kinetics of metronidazole in children. Eur J Clin Pharmacol (1983) 0.86
Histidine-rich glycoprotein blocks T cell rosette formation and modulates both T cell activation and immunoregulation. J Biol Chem (1989) 0.86
Prognostic impact of tumor perfusion in MR-imaging studies in Ewing tumors. Strahlenther Onkol (2001) 0.85
Targeting the EWS-FLI1 transcription factor in Ewing sarcoma. Cancer Chemother Pharmacol (2015) 0.84
High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastoma. Med Pediatr Oncol (1994) 0.84
Urological treatment and clinical course of BK polyomavirus-associated hemorrhagic cystitis in children after bone marrow transplantation. Eur Urol (1999) 0.84
[On the excretion of azlocillin with bronchial secretion in children (author's transl)]. Arzneimittelforschung (1979) 0.84
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation. J Clin Oncol (1993) 0.84
Thrombocytopenia and complement activation under recombinant TNF alpha/IFN gamma therapy in man. Ann Hematol (1997) 0.84
Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants. Eur J Pediatr (2000) 0.83
Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation. Eur J Pediatr (1999) 0.83
CD25 blockade protects T cells from activation-induced cell death (AICD) via maintenance of TOSO expression. Scand J Immunol (2009) 0.83
Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation. Bone Marrow Transplant (1994) 0.83
[Results of treatment of primary exclusively pulmonary metastatic Ewing sarcoma. A retrospective analysis of 41 patients]. Klin Padiatr (1993) 0.83
The development of circadian rhythmicity in neonates. Early Hum Dev (1994) 0.83
The role of chemotherapy in the treatment of children with neuroblastoma stage IV: the GPO (German Pediatric Oncology Society) experience. Klin Padiatr (1990) 0.82
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment. Br J Cancer (2013) 0.82
Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. J Pediatr (1991) 0.82
Interleukin 6-induced differentiation of a human B cell line into IgM-secreting plasma cells is mediated by c-fos. Eur J Immunol (1992) 0.82
Treatment with cyclosporin A in a patient with Omenn's syndrome. Arch Dis Child (2002) 0.82
[Therapy of osteoid osteomas -- always surgically?]. Klin Padiatr (2003) 0.81
Defective interferon gamma production in neonatal T cells is independent of interleukin-2 receptor binding. Pediatr Res (1991) 0.81
Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann Hematol (1997) 0.81
[Epidural haematoma in a newborn]. Z Geburtshilfe Neonatol (2005) 0.81
Unusual presentation of central nervous system relapse with oculomotor nerve palsy in a case of CD56-positive acute myeloid leukemia following allogeneic stem cell transplantation. Pediatr Transplant (2002) 0.81
DNA-microarrays as tools for the identification of tumor specific gene expression profiles: applications in tumor biology, diagnosis and therapy. Klin Padiatr (2003) 0.81
[Acute encephalopathy in salmonella infection]. Klin Padiatr (2007) 0.81
[Preparation and monitoring of sedation and analgosedation carried out by pediatricians and pediatric training assistants]. Klin Padiatr (2008) 0.80
Differential production of interleukin-3 in human T lymphocytes following either CD3 or CD2 receptor activation. Exp Hematol (1996) 0.80
Experience with amoxycillin in neonates and premature babies. Int J Clin Pharmacol Biopharm (1977) 0.80
[Comparison of public health systems within the European Community]. Gesundheitswesen (1994) 0.80
The role of interleukin-10 (IL-10) in IL-15-mediated T-cell responses. Blood (1997) 0.80
[Molecular genetic detection of t(11;22)(q24;12) translocation in Ewing sarcoma and malignant peripheral neuroectodermal tumors]. Pathologe (1994) 0.80
Tolerability of piperacillin/tazobactam in children and adolescents after high dose radio-/chemotherapy and autologous stem cell transplantation. Infection (1998) 0.80
The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study. Int J Biol Res Pregnancy (1982) 0.79
Management of oncology patients admitted to the paediatric intensive care unit of a general children's hospital - a single center analysis. Klin Padiatr (2011) 0.79
Bone marrow fibroblasts from children with aplastic anemia exhibit reduced interleukin-6 production in response to cytokines and viral challenge. Pediatr Res (1995) 0.79
Glycogen storage disease type Ib: infectious complications and measures for prevention. Eur J Pediatr (1993) 0.79
Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy. Z Rheumatol (2002) 0.79
[High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS]. Klin Padiatr (1999) 0.79
Does megatherapy contribute to survival in metastatic neuroblastoma? A retrospective analysis. German Cooperative Neuroblastoma Study Group. Klin Padiatr (1997) 0.78
Amoxicillin in paediatrics, with special reference to its excretion into bronchial secretion. Int J Clin Pharmacol Ther Toxicol (1980) 0.78
Expression of the CEA gene family members NCA-50/90 and NCA-160 (CD66) in childhood acute lymphoblastic leukemias (ALLs) and in cell lines of B-cell origin. Leukemia (1994) 0.78
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells. Bone Marrow Transplant (1997) 0.78
A two-dose schedule for immunization of infants against diphtheria, pertussis and tetanus. J Biol Stand (1980) 0.78
Interleukin 10 induced c-fos expression in human B cells by activation of divergent protein kinases. Immunol Invest (1996) 0.78
Reversible brain MRI changes in acyclovir neurotoxicity. Bone Marrow Transplant (1997) 0.78
Vancomycin minimal inhibitory concentration from broth microdilution and Etest in respiratory tract samples of patients with ventilation-associated pneumonia. J Hosp Infect (2010) 0.78
[Detection of EWS-/FLI-1 gene fusion transcripts by RT-PCR as a tool in the diagnosis of tumors of the Ewing sarcoma group]. Verh Dtsch Ges Pathol (1994) 0.78
[Uncommon presentation of tuberous sclerosis in an infant]. Arch Pediatr (2011) 0.78
A controlled trial of recombinant human erythropoietin after bone marrow transplantation. Blood (1994) 0.77
IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein. Leukemia (1995) 0.77
Radiotherapy and high-dose chemotherapy in advanced Ewing's tumors. Strahlenther Onkol (1999) 0.77
[Significance of interleukin 10 for acute graft versus host disease in children and adolescents after allogenic bone marrow transplantation]. Klin Padiatr (1996) 0.77
Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry. Bone Marrow Transplant (1996) 0.77
Biology and pharmacology of hematopoietic growth factors. Med Pediatr Oncol Suppl (1992) 0.77
Release of the soluble interleukin-6 receptor from human T-cells. Immunol Invest (1998) 0.77
Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2. J Immunol (1987) 0.77
A new perfusion cell chamber system for determination of heat shock effects by means of video-enhanced microscopy. Med Biol Eng Comput (1999) 0.77
Comparison between human immunodeficiency virus positive and negative patients with tuberculosis in Southern Brazil. Mem Inst Oswaldo Cruz (1999) 0.77
Growth factors and hemostasis: differential effects of GM-CSF and G-CSF on coagulation activation--laboratory and clinical evidence. Ann Hematol (2001) 0.77
Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies. Exp Hematol (1995) 0.77
Interleukin-10 directly inhibits the interleukin-6 production in T-cells. Scand J Immunol (1995) 0.77
Studies on the activity of a new antimycotic (Bay b 5097) in children. Int J Clin Pharmacol (1972) 0.77
Only therapeutic ICOS:ICOSL blockade alleviates acute graft versus host disease. Klin Padiatr (2009) 0.77
Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro. J Cancer Res Clin Oncol (1993) 0.76
Interaction between interleukin 10 and interleukin 6 in human B-cell differentiation. Immunol Invest (1998) 0.76
[Acute alcohol intoxication in adolescents: preliminary results of a pilot project in Munich]. Dtsch Med Wochenschr (2009) 0.76
A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies. Leukemia (1999) 0.76
Systemic activation of the immune system during ganciclovir treatment following intratumoral herpes simplex virus type 1 thymidine kinase gene transfer in an adolescent ependymoma patient. Neuropediatrics (2002) 0.76